about
Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of diseaseAlopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areataOral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.Genetic basis of alopecia areata: a roadmap for translational research.Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor BaricitinibTranscriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes.Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.Master regulators of infiltrate recruitment in autoimmune disease identified through network-based molecular deconvolution.The generation and modulation of antigen-specific memory CD8 T cell responses.Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA).Molecular signatures define alopecia areata subtypes and transcriptional biomarkersDominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis.CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis.A role for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes.Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation.Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areataSingle-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression
P50
Q34408063-8F619EC1-CAD9-4B1A-B6D6-9F287BD9B908Q34433867-640253FF-F185-41DC-A6FA-2F35F6D39B07Q34523843-2350820A-3A73-4D9D-99B8-1F3A6F21E687Q34541893-EE683B52-1748-4008-A254-153156C01C9EQ34541899-8F9D51CB-CE73-4144-8274-4DA75459042EQ35184592-C61D3022-9614-4112-8474-9406DED2DBD1Q35800753-22B10569-F389-448D-8095-E5F9B1C418F0Q36053525-F7C98BD3-8092-410A-BCF5-C73B4F81B668Q36228495-1933AB3D-DBB6-42C9-9E3D-D223709320FAQ36350069-E830BD9D-E4EB-4392-A4D7-3E695E5818C9Q36473557-E866B090-7F26-4DB2-83B2-77DA0C349E71Q36479531-76D1E3F9-06E2-4BA4-83AF-266E0557A5F8Q37008476-F3EFE74A-EB02-4A55-926E-D4D41874B611Q37381187-A7E3D5E1-0A45-4CF6-B18A-0BA77E0A7D87Q39604573-A38468B9-AAF8-4A62-B32F-5EAA3467752CQ49923388-C053435D-6828-42CF-B2D0-D2D83CEECC8EQ51973116-F2EBFE52-C794-4083-A686-D86FB6589623Q51981911-56EB021C-30C8-451E-829E-332F82089F49Q51988170-EEC4B34C-7E89-4D09-B78A-610929E12CD7Q51991275-1EBFAC1E-87F5-4980-AD42-F06198B67803Q53577471-2236F9C4-A987-4B33-9F26-AD939F1269CEQ57029272-4642C679-265C-4B6B-A8AC-9C915CDD4314Q91339867-9F4ED0DD-0F03-433E-997E-E808BDDD8FFD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ali Jabbari
@ast
Ali Jabbari
@en
Ali Jabbari
@es
Ali Jabbari
@nl
Ali Jabbari
@sl
type
label
Ali Jabbari
@ast
Ali Jabbari
@en
Ali Jabbari
@es
Ali Jabbari
@nl
Ali Jabbari
@sl
prefLabel
Ali Jabbari
@ast
Ali Jabbari
@en
Ali Jabbari
@es
Ali Jabbari
@nl
Ali Jabbari
@sl
P108
P106
P21
P31
P496
0000-0002-8559-7314